Sanara MedTech Inc.
For the period ended Dec 31, 2025. Filed Mar 24, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 24, 2026
SMTI$32.10+1.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Changes in Shareholders’ Equity
| Common Stock $0.001 par value · Additional Paid-In · Accumulated · Noncontrolling · Total Shareholders’ | ||||||
|---|---|---|---|---|---|---|
| Shares | Amount | Capital | Deficit | Interest | Equity | |
| Balance at December 31, 2023 | 8,535,239 | $8,535 | $72,860,556 | $(28,036,814) | $(244,260) | $44,588,017 |
| Share-based compensation | 164,451 | 165 | 4,435,883 | - | - | 4,436,048 |
| Net settlement and retirement of equity-based awards | 54,083 | 54 | (42,228) | (83,031) | - | (125,205) |
| Issuance of common stock in equity offering | - | - | (75,000) | - | - | (75,000) |
| Net loss | - | - | - | (9,664,547) | (247,351) | (9,911,898) |
| Balance at December 31, 2024 | 8,753,773 | $8,754 | $77,179,211 | $(37,784,392) | $(491,611) | $38,911,962 |
| Share-based compensation | 195,834 | 196 | 5,154,565 | - | - | 5,154,761 |
| Net settlement and retirement of equity-based awards | (2,694) | (2) | (590,948) | 43,956 | - | (546,994) |
| Change in noncontrolling interest | - | - | (510,292) | - | 488,386 | (21,906) |
| Net loss | - | - | - | (37,562,606) | (5,441) | (37,568,047) |
| Balance at December 31, 2025 | 8,946,913 | $8,948 | $81,232,536 | $(75,303,042) | $(8,666) | $5,929,776 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.